Skip to content
Evigrade
CriticalSSRI (selective serotonin reuptake inhibitor)×Selective irreversible MAO-B inhibitor

Updated · Methodology

Mechanism

Selegiline irreversibly inhibits the enzyme monoamine oxidase (MAO) type B. At the recommended dose of 5–10 mg a day it acts selectively on MAO-B, and above 10 mg a day it may lose this selectivity (selegiline summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). After a single 10 mg dose of selegiline, platelet MAO-B activity returns to normal in about 2 weeks, as the body makes new enzyme (selegiline SmPC, AEMPS). MAO takes part in the breakdown of serotonin (selegiline label, US Food and Drug Administration, FDA). Citalopram is a selective serotonin reuptake inhibitor (SSRI), so the Spanish selegiline SmPC contraindicates combining selegiline with SSRIs because of the risk of serotonin syndrome (citalopram and selegiline SmPCs, AEMPS). Serotonin syndrome, including fatal cases, has been reported in people taking selegiline together with antidepressants, and the mechanism of these reactions is not fully understood (selegiline FDA label). In a study described in the Spanish citalopram SmPC, citalopram 20 mg a day given with selegiline 10 mg a day showed no clinically relevant interaction (citalopram SmPC, AEMPS).

Symptoms

Selegiline combined with selective serotonin reuptake inhibitors (SSRIs), the class citalopram belongs to, may cause confusion, hypomania, hallucinations and manic episodes, agitation, myoclonus, overactive reflexes, poor coordination, shivering, tremor, seizures, ataxia, sweating, diarrhoea, fever and high blood pressure, all of which can be part of serotonin syndrome (selegiline summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Serious and sometimes fatal reactions have been reported in people taking an SSRI together with a monoamine oxidase (MAO) inhibitor, including selegiline, or starting an MAO inhibitor soon after stopping an SSRI (citalopram SmPC, AEMPS). They included hyperthermia, rigidity, myoclonus, autonomic instability with rapid swings in vital signs, and mental changes ranging from confusion and irritability to extreme agitation, delirium and coma (citalopram SmPC, AEMPS). A combination of agitation, tremor, myoclonus and raised temperature may signal that the syndrome is developing (citalopram SmPC, AEMPS).

Management

The combination is contraindicated. The Spanish selegiline summary of product characteristics (SmPC) prohibits selegiline with selective serotonin reuptake inhibitors (SSRIs) as a class and lists the combination as contraindicated. According to its own SmPC, citalopram belongs to this class (selegiline and citalopram SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS). The US citalopram label contraindicates citalopram with any monoamine oxidase (MAO) inhibitor and within 14 days of stopping one, and the US selegiline labels describe selegiline as an irreversible MAO inhibitor (citalopram and selegiline labels, US Food and Drug Administration, FDA). The Spanish citalopram SmPC is less strict: it contraindicates selegiline only at doses above 10 mg a day and otherwise lists the combination as requiring caution (citalopram SmPC, AEMPS). The strictest document takes precedence. Start citalopram no earlier than 14 days after stopping selegiline (citalopram SmPC, AEMPS, for irreversible MAO inhibitors; citalopram and selegiline FDA labels). When switching the other way, stop citalopram at least 7 days before the first dose of selegiline (citalopram SmPC, AEMPS). If a patient is nevertheless taking both drugs and signs of serotonin syndrome appear, stop citalopram and selegiline at once and start supportive symptomatic treatment (citalopram SmPC, AEMPS, and FDA label; selegiline patch FDA label). Do not prescribe selegiline above the recommended 10 mg a day (selegiline capsules FDA label).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Citalopram

Other interactions with Selegiline